After anti‑CD138 binding and protease unmasking at the tumor site, the released IFN‑α binds IFNAR1/2 on nearby cells, activating IFNAR–JAK/STAT signaling that induces antiproliferative/apoptotic programs leading to cell death (independent of T‑cell engagement).